/content/dam/www/people-profile-photos/l/paul-lampe/paul-lampe-d.jpg
Lampe
Paul Lampe, PhD

Paul Lampe, PhD

  • Professor and Program Head, Translational Research Program, Public Health Sciences Division, Fred Hutch
  • Affiliate Investigator, Human Biology Division, Fred Hutch
  • Research Professor, Global Health, University of Washington School of Public Health and Community Medicine
206.667.4123
206.667.2537

Background

Dr. Paul Lampe is head of the Translational Research Program at Fred Hutch. The overarching goal of this program is to discover and translate molecular and epidemiologic findings to advance our understanding of the biological basis for various exposure-biomarker-disease relationships. Accomplishing this goal will improve precision prevention and interception, risk assessment, early detection, treatment decision making, prognostication and survivorship. Dr. Lampe’s research focuses on the discovery of molecules called biomarkers that can be used for the early detection of colon, breast, lung and pancreatic cancers. He also studies the cell biology of cancer and its development, particularly communication gateways between cells called gap junctions. When functioning properly, gap junctions relay molecular messages that help control key biological activities. Examples include coordinating the rhythmic contraction of the heart muscle and regulating normal cell growth. Dr. Lampe and colleagues discovered that when gap junctions are absent or damaged, serious health consequences, including cancer, can result.

Education

PhD, Biochemistry, University of Minnesota, 1984

Current Projects

Discovery of Cancer Biomarkers via Proteomics

The Functional Consequences of Gap Junctional Regulation

Find a Clinical Trial Led by Dr. Lampe

Stories

All news
Lung cancer researchers, advocates gather in Seattle SPORE scientists talk T cells, new targeted therapies, the tumor microenvironment and more at annual meeting June 17, 2026
New program to fast-track lung cancer research from lab to clinic Patient-focused science at the heart of $13M National Cancer Institute grant August 6, 2019
Could a simple blood test replace the invasive tissue biopsy? Answer: It’s complicated … April 2, 2019